Crossmark

Lactobacillus murinus alleviate intestinal ischemia/reperfusion injury through promoting the release of interleukin-10 from M2 macrophages via Toll-like receptor 2 signaling

Crossref DOI link: https://doi.org/10.1186/s40168-022-01227-w

Published Online: 2022-03-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hu, Jingjuan

Deng, Fan

Zhao, Bingcheng

Lin, Zebin

Sun, Qishun

Yang, Xiao

Wu, Mei

Qiu, Shida

Chen, Yu

Yan, Zhengzheng

Luo, Sidan

Zhao, Jin

Liu, Weifeng

Li, Cai

Liu, Ke Xuan https://orcid.org/0000-0003-0221-366X
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81730058, 81671955, 82902010)

China Postdoctoral Science Foundation (2021M701611)
License Information

Text and Data Mining valid from 2022-03-03

Version of Record valid from 2022-03-03
More Information

Article History

Received: 17 December 2021

Accepted: 7 January 2022

First Online: 3 March 2022

Declarations

:

: All animal experimental procedures were approved by the local Animal Care and Use Committee of the Nanfang hospital of Southern Medical University (approval number NFYY-2019-247). The study protocol was approved by the Ethical Committee of Nanfang hospital, Southern Medical University (approval number NFEC-202009-k2-01), and informed consent was obtained from participants.

: Not applicable.

: All authors declare that they have no competing interests.

Document is current

Any future updates will be listed below